Brian Badgwell

Oct 24, 2024 | ejso.com | Brian Badgwell |Neal Bhutiani |Y. Seo |Kristen Robinson |Michael White |Naruhiko Ikoma | +4 more

KeywordsHIPECgastric cancersurvivalGet full text accessLog in, subscribe or purchase for full access. References1. Ikoma, N. ∙ Chen, H.C. ∙ Wang, X. ... Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative TherapyAnnals of surgical oncology. Sep 2017; 24:2679-26872. Franko, J. ∙ Shi, Q. ∙ Meyers, J.P. ...

Oct 21, 2024 | nature.com | Brian Badgwell

Adjuvant chemoradiotherapy has a proven survival benefit for patients undergoing upfront resection of gastric cancer compared with surgery alone. Now, data from the TOPGEAR trial demonstrate that adding radiotherapy to standard-of-care perioperative chemotherapy offers no additional survival benefit. I discuss the implications for treatment and future research.